RGD Reference Report - Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Effects of resveratrol on biomarkers of oxidative stress and on the activity of delta aminolevulinic acid dehydratase in liver and kidney of streptozotocin-induced diabetic rats.

Authors: Schmatz, Roberta  Perreira, Luciane Belmonte  Stefanello, Naiara  Mazzanti, Cinthia  Spanevello, Roselia  Gutierres, Jessié  Bagatini, Margarete  Martins, Caroline Curry  Abdalla, Fátima Husein  Daci da Silva Serres, Jonas  Zanini, Daniela  Vieira, Juliano Marchi  Cardoso, Andréia Machado  Schetinger, Maria Rosa  Morsch, Vera Maria 
Citation: Schmatz R, etal., Biochimie. 2012 Feb;94(2):374-83. doi: 10.1016/j.biochi.2011.08.005. Epub 2011 Aug 16.
RGD ID: 12904702
Pubmed: PMID:21864646   (View Abstract at PubMed)
DOI: DOI:10.1016/j.biochi.2011.08.005   (Journal Full-text)

The present study investigated the effects of resveratrol (RV), a polyphenol with potent antioxidant properties, on oxidative stress parameters in liver and kidney, as well as on serum biochemical parameters of streptozotocin (STZ)-induced diabetic rats. Animals were divided into six groups (n = 8): control/saline; control/RV 10 mg/kg; control/RV 20 mg/kg; diabetic/saline; diabetic/RV10 mg/kg; diabetic/RV 20 mg/kg. After 30 days of treatment with resveratrol the animals were sacrificed and the liver, kidney and serum were used for experimental determinations. Results showed that TBARS levels were significantly increased in the diabetic/saline group and the administration of resveratrol prevented this increase in the diabetic/RV10 and diabetic/RV20 groups (P < 0.05). The activities of catalase (CAT), superoxide dismutase (SOD) and aminolevulinic acid dehydratase (d-ALA-D) and the levels of non protein thiols (NPSH) and vitamin C presented a significant decrease in the diabetic/saline group when compared with the control/saline group (P < 0.05). The treatment with resveratrol was able to prevent these decrease improving the antioxidant defense of the diabetic/RV10 and diabetic/RV20 groups (P < 0.05). In addition, the elevation in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamiltransferase (γ-GT) activities as well as in levels of urea, creatinine, cholesterol and triglycerides observed in the diabetic/saline group were reverted to levels close to normal by the administration of resveratrol in the diabetic/RV10 and diabetic/RV20 groups (P < 0.05). These findings suggest that resveratrol could have a protector effect against hepatic and renal damage induced by oxidative stress in the diabetic state, which was evidenced by the capacity of this polyphenol to modulate the antioxidant defense and to decrease the lipid peroxidation in these tissues.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Experimental Diabetes Mellitus treatmentISOAlad (Rattus norvegicus)12904702; 12904702 RGD 
Experimental Diabetes Mellitus treatmentIDA 12904702 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Alad  (aminolevulinate dehydratase)

Genes (Mus musculus)
Alad  (aminolevulinate, delta-, dehydratase)

Genes (Homo sapiens)
ALAD  (aminolevulinate dehydratase)


Additional Information